CID 135433321

2-[2-(3-allyl-2-hydroxybenzylidene)hydrazino]-n-(4-methylphenyl)-2-oxoacetamide

Structural Information

Molecular Formula
C19H19N3O3
SMILES
CC1=CC=C(C=C1)NC(=O)C(=O)N/N=C/C2=CC=CC(=C2O)CC=C
InChI
InChI=1S/C19H19N3O3/c1-3-5-14-6-4-7-15(17(14)23)12-20-22-19(25)18(24)21-16-10-8-13(2)9-11-16/h3-4,6-12,23H,1,5H2,2H3,(H,21,24)(H,22,25)/b20-12+
InChIKey
GPZXJWHMYOFXOC-UDWIEESQSA-N
Compound name
N'-[(E)-(2-hydroxy-3-prop-2-enylphenyl)methylideneamino]-N-(4-methylphenyl)oxamide
Related CIDs

2D Structure

compound 2d structure
1
Annotation Hits

6
References

0
Patents

337.14264 Da
Monoisotopic Mass

3.5
XlogP (predicted)

Profile

Predicted Collision Cross Section

Adduct m/z Predicted CCS (Ų)
[M+H]+ 338.14992 182.1
[M+Na]+ 360.13186 192.2
[M+NH4]+ 355.17646 187.1
[M+K]+ 376.10580 185.9
[M-H]- 336.13536 185.8
[M+Na-2H]- 358.11731 188.1
[M]+ 337.14209 184.1
[M]- 337.14319 184.1
m/z: mass to charge ratio of the adduct.
Predicted Collision Cross Section (CCS) values (Ų) per adduct calculated using CCSbase.

Literature stripe

literature stripe

Patent stripe

No patent data available for this compound.